Prestige BioPharma 950210 Total Debt

950210 Total Debt in 2022: $38.84M

According to Prestige BioPharma latest financial reports the total debt is $38.84M, an increase of 1839.71% to 2022. At the end of 2022 company had $2.00M total debt. This figure represents the debts and financial obligations that Prestige BioPharma combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.

Prestige BioPharma 950210 Total Debt History from 2023 to 2022

950210 Total Debt by year

View the Top Total Debt Stocks